Approval · Notice of Compliance 36217 · 2025
BRIMONIDINE: Notice of Compliance 36217
Issued October 21, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36217
- Date
- October 21, 2025
- Company
- Steri-Med Pharma Inc.Upton, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- ALPHAGAN (Allergan Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRIMONIDINE | 02562316 | Marketed |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.2 PER